A.G. Unnikrishnan
Dr. A.G. Unnikrishnan is the CEO of Chellaram Diabetes Institute, recognized for his contributions to endocrinology. He emphasizes the broader systemic health benefits of Wegovy, including improvements in insulin function and potential neuroprotective effects.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
India:
Dr. A.G. Unnikrishnan highlights the potential neuroprotective benefits of Wegovy.
8